| Trial Identifier: | D8820C00001 |
| Sponsor: | AstraZeneca |
| Start Date: | April 2024 |
| Primary Completion Date: | December 2024 |
| Study Completion Date: | December 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| US, Connecticut | Hamden, Connecticut, US, 06518 |
| USA, CA | Sacramento, CA, USA, 95817 |
| USA, MA | Boston, MA, USA, 02114 |
| USA, MA | Boston, MA, USA, 02115 |
| USA, MO | St. Louis, MO, USA, 63110 |
| USA, SC | Charleston, SC, USA, 29425 |
| USA, VA | Charlottesville, VA, USA, 22903 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company